Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,556.00    -8.00 (-0.51%)
Bid:
1,552.00
Ask:
1,560.00
Spread: 8.00 (0.515%)
Market Cap: £809.79m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

PDMR transactions

18 Jul 2024 14:04

RNS Number : 9833W
M. P. Evans Group PLC
18 July 2024
 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

M.P. Evans Group Plc

(the "Company" or "M.P. Evans")

 

PDMR transactions

 

PDMR transactions

 

The Company has been notified of the exercise of share options under the M.P. Evans Group PLC Long Term Incentive Scheme by K. Chandra Sekaran, a director of the Company. K. Chandra Sekaran exercised his share options over 3,000 shares of 10p each in the capital of the Company ("Shares") granted at nil cost per Share and due to expire on 30 June 2031. This award was satisfied out of shares held by the Trustee of the M.P. Evans Group 2018 Employees' Benefit Trust.

 

 

 1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

K. Chandra Sekaran

2

Reason for the notification

 

a)

Position/status

 

Non-executive director

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

M.P.Evans Group PLC

b)

LEI

 2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Shares of 10 pence per share in M.P.Evans Group PLC ("Shares").

 

Identification code: ISIN GB007538100

 

b)

Nature of the transaction

Exercise of options over Shares

 

c)

Price(s) and volume(s)

 

 

Exercise of share options over Shares:

Price(s) Nil

Volume(s) 3,000

 

 

d)

Aggregated information

 

N/A

 

e)

Date of transaction

10 July 2024

 

f)

Place of transaction

Outside a trading venue

 

18 July 2024

 

 

Enquiries:

 

M.P. Evans Group PLC

Tel: +44 (0)1892 516333

Peter Hadsley-Chaplin - Chairman

Matthew Coulson - Chief executive

Luke Shaw - Chief financial officer

Cavendish Capital Markets Limited (Nomad and broker)

Tel: +44 (0)20 7220 0500

Matt Goode, George Lawson, Rory Sale - Corporate finance

Tim Redfern, Harriet Ward - Equity capital markets

Hudson Sandler (Financial PR)

Tel: +44 (0)20 7796 4133

Charlie Jack, Charlotte Cobb, Francis Kerrigan

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIVDVITLIS
Date   Source Headline
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20235:07 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSAcquisition
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 202310:35 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in Own Shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
17th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
11th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
9th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20237:00 amRNSTransaction in Own Shares
2nd Oct 20232:14 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSPublication of TCFD report
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20232:41 pmRNSAIM Rule 20 Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.